Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre” or the “Company”) (TSX-V: VO; OTCQB: KVLQF; FRANKFURT: KEQ0) today announced a non-brokered private placement of convertible unsecured debentures (the “Debentures”) for aggregate gross proceeds of up to CDN$2,000,000 (the “Offering”). The Debentures will bear interest at a rate of 6% per annum and will mature on the date that is 18 months from the date of issuance (the “Maturity Date”). The principal amount of the Debentures will be convertible, at the option of the holder at any time after the date six months from the issue date, into units (the “Units”) of the Company at a conversion price of $0.12 per Unit (the “Conversion Price”). Each Unit...

In SELVA Phase 3 study, 100% of participants (13/13) aged 6–11 years were rated as “Much Improved” (+2) or “Very Much Improved” (+3) on the Microcystic Lymphatic Malformation Investigator Global Assessment (mLM-IGA) scale at Week 24, with a mean improvement of +2.46 (p

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 25, 2026 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. The notice of meeting is available on the Cellectis website: https://www.cellectis.com/en/investors/general-meetings/ About Cellectis     Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR...

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the William Blair 46th Annual Growth Stock Conference in Chicago on Tuesday, June 2, 2026. The Company’s presentation will begin at 10:40 a.m. (CT). A live webcast of the event can be found at ir.cvrx.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time. About CVRx, Inc. CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for...

OMAHA, Neb., May 20, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus” or “the company”), a leading self-custodial finance and cryptocurrency platform, today announced updated digital asset holdings, user metrics, and exchange provider processed volume metrics, as of April 30, 2026. “We’re building a business where the topline holds up when consumer trading softens, and the partner channel is part of that work,” said James Gernetzke, CFO at Exodus. “XO Swap volume grew 44% month-over-month in April to $98 million and now represents 28% of total swap volume, up from 20% in March — the highest partner mix share since November.” “We spent a decade building a place where consumers could hold their assets. Now we’ve built a place where they can spend...

HOUSTON, May 20, 2026 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) today announced that the Company will webcast its presentation from the 2026 Deutsche Bank Access Global Consumer Conference in Paris, France on Tuesday, June 2, at 8:45 a.m. CT or 3:45 p.m. CEST. The live webcast for the event can be accessed at investors.sysco.com. An archived replay of the webcast will be available shortly after the live event is completed. For purposes of public disclosure, including this and future similar events, Sysco uses the investor relations portion of its website as the primary channel for publishing key information to its investors, some of which may contain material and previously non-public information. About Sysco Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare...

BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June. Jefferies Global Healthcare Conference Wednesday, June 3, 2026Marriott Marquis, New York CityManagement will participate in a fireside chat at 10:30 AM EDT Goldman Sachs Annual Global Healthcare ConferenceWednesday, June 10, 2026Loews Miami Beach Hotel, Miami BeachManagement will present at 9:20 AM EDT About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional...